Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Proneurotensin/neuromedin N secreted from small cell lung carcinoma cell lines as a potential tumor marker.

Ogura S, Kaneko K, Miyajima S, Ohshima K, Yamaguchi K, Mochizuki T.

Proteomics Clin Appl. 2008 Dec;2(12):1620-7. doi: 10.1002/prca.200800039. Epub 2008 Nov 14.

PMID:
21136812
2.

Investigation of proNT/NMN secretion from small cell lung carcinoma cells using a mouse xenograft model.

Wakabayashi-Nakao K, Maruyama K, Ishii H, Muramatsu K, Hatakeyama K, Ohshima K, Ogura S, Nakajima T, Yamaguchi K, Mochizuki T.

Oncol Rep. 2012 Oct;28(4):1181-6. doi: 10.3892/or.2012.1926. Epub 2012 Jul 23.

PMID:
22825476
3.

Proteomic analysis of secreted proteins of non-small cell lung cancer.

Huang LJ, Chen SX, Luo WJ, Jiang HH, Zhang PF, Yi H.

Ai Zheng. 2006 Nov;25(11):1361-7.

PMID:
17094902
4.

Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.

Cardona C, Rabbitts PH, Spindel ER, Ghatei MA, Bleehen NM, Bloom SR, Reeve JG.

Cancer Res. 1991 Oct 1;51(19):5205-11.

5.

Insulin-like growth factor expression in human cancer cell lines.

Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL, Cuttitta F.

J Biol Chem. 1996 May 10;271(19):11477-83.

6.

Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer.

Huang LJ, Chen SX, Huang Y, Luo WJ, Jiang HH, Hu QH, Zhang PF, Yi H.

Lung Cancer. 2006 Oct;54(1):87-94. Epub 2006 Jul 31.

PMID:
16876904
7.

Expression of insulinlike growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines.

Reeve JG, Brinkman A, Hughes S, Mitchell J, Schwander J, Bleehen NM.

J Natl Cancer Inst. 1992 Apr 15;84(8):628-34.

PMID:
1372941
8.

Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines.

Heidtmann HH, Salge U, Havemann K, Kirschke H, Wiederanders B.

Oncol Res. 1993;5(10-11):441-51.

PMID:
8054705
9.

A new possible lung cancer marker: VGF detection from the conditioned medium of pulmonary large cell neuroendocrine carcinoma-derived cells using secretome analysis.

Matsumoto T, Kawashima Y, Nagashio R, Kageyama T, Kodera Y, Jiang SX, Okayasu I, Kameya T, Sato Y.

Int J Biol Markers. 2009 Oct-Dec;24(4):282-5.

PMID:
20082272
10.
11.

Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype.

Vos MD, Scott FM, Iwai N, Treston AM.

J Cell Biochem Suppl. 1996;24:257-68.

PMID:
8806108
12.

Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?

Shia J, Tang LH, Weiser MR, Brenner B, Adsay NV, Stelow EB, Saltz LB, Qin J, Landmann R, Leonard GD, Dhall D, Temple L, Guillem JG, Paty PB, Kelsen D, Wong WD, Klimstra DS.

Am J Surg Pathol. 2008 May;32(5):719-31. doi: 10.1097/PAS.0b013e318159371c.

PMID:
18360283
13.

A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma.

Mlynarek AM, Balys RL, Su J, Hier MP, Black MJ, Alaoui-Jamali MA.

Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):910-8.

PMID:
17875858
14.

Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation.

Ernst A, Hellmich S, Bergmann A.

Peptides. 2006 Jul;27(7):1787-93. Epub 2006 Mar 7.

PMID:
16519961
16.

Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.

Qiao H, Hung W, Tremblay E, Wojcik J, Gui J, Ho J, Klassen J, Campling B, Elliott B.

J Cell Biochem. 2002;86(4):665-77.

PMID:
12210733
17.

Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma.

Ameshima S, Ishizaki T, Demura Y, Imamura Y, Miyamori I, Mitsuhashi H.

Cancer. 2000 Oct 1;89(7):1448-56.

PMID:
11013357
18.

Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.

Brower M, Carney DN, Oie HK, Gazdar AF, Minna JD.

Cancer Res. 1986 Feb;46(2):798-806.

19.

Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell lines.

McLemore TL, Adelberg S, Czerwinski M, Hubbard WC, Yu SJ, Storeng R, Wood TG, Hines RN, Boyd MR.

J Natl Cancer Inst. 1989 Dec 6;81(23):1787-94.

PMID:
2555530
20.

Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.

Ozaki Y, Kontani K, Hanaoka J, Chano T, Teramoto K, Tezuka N, Sawai S, Fujino S, Yoshiki T, Okabe H, Ohkubo I.

Cancer. 2002 Nov 1;95(9):1954-62.

Supplemental Content

Support Center